FDA Reviews Tumor Reports Linked to Novartis Gene Therapy
The review follows nine reported tumors among Zolgensma patients, including two cases with evidence involving the treatment’s viral carrier.
Makkler Newsroom · Nov 7, 02:35 PM · 1 min read
Market closed· · ZAc · Data may be delayed
Not enough data
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.